法律意见书 北京中伦（成都）律师事务所 关于尚纬股份有限公司 2025 年第三次临时股东会的 法律意见书 致：尚纬股份有限公司 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共 和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》（以下简称"《股 东会规则》"）等法律、法规及规范性文件及《尚纬股份有限公司章程》（以下 简称"《公司章程》"）的规定，北京中伦（成都）律师事务所（以下简称"中伦" 或"本所"）接受尚纬股份有限公司（以下简称"公司"）的委托，指派本所律 师见证了公司 2025 年第三次临时股东会（以下简称"本次股东会"）并对本次 股东会的相关事项出具本法律意见书。 为出具本法律意见书，中伦律师审查了以下文件： 1. 《公司章程》； 2. 公司第六届董事会第五次会议决议； 3. 《关于召开 2025 年第三次临时股东会的通知》； 在本法律意见书中，中伦律师仅对本次股东会的召集、召开程序、出席会议 人员资格、召集人资格及会议表决程序、表决结果是否符合《公司法》等法律、 法规、规范性文件及《公司章程》的规定发表意见，不对会议审议的议案内容以 及该等议案所表述的事实或数据的真实 ...

证券代码：603333 证券简称：尚纬股份 公告编号：2025-074 尚纬股份有限公司 2025年第三次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 (一)股东会召开的时间：2025 年 12 月 10 日 (二)股东会召开的地点：四川省乐山高新区迎宾大道 18 号 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 379 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 123,782,950 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 26.6803 | 注：出席会议的股东所持有表决权股份数占公司有表决权股份总数（扣除回购账户股份数） 的比例为 27.70% (四)表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次会议由公司董事会召集，公司董事长叶洪林主持。本次会议的召开符合《中 华人民共和国公司法》、《上市公司股东会规则》和《公 ...

中化新网讯11月24日，尚纬股份（603333）发布公告称，拟以5.2亿元对四川中氟泰华新材料科技有限 公司(以下简称四川中氟泰华)进行增资。增资完成后，四川中氟泰华注册资本将从5亿元增至10.2亿元， 尚纬股份将持有其51%股权。 公告披露，四川中氟泰华及其股东深圳中氟泰华新材料科技有限公司均为尚纬股份控股股东福华通达化 学股份公司(以下简称福华化学)控制的企业。本次增资拟使用自有资金2.2亿元，福华化学提供3亿元专 项借款，增资款项将全部用于四川中氟泰华现有及规划项目建设，标的公司需按月向尚纬股份提交资金 使用明细。 尚纬股份表示，本次增资是其拓展电子化学品业务的重要举措，将助力公司从单一特种电缆制造向"电 缆+化学品"双轮驱动模式转型，培育第二增长曲线。 ...

Core Insights - Wind energy stands out among renewable energy sources due to its economic viability, rapid development, and strong commercialization potential [1][4] - The demand for wind energy cables is increasing significantly due to advancements in wind power technology, making it a rising star in the cable industry [1][6] - The market size of China's wind energy cable industry is projected to reach 47.4 billion yuan in 2024, representing a year-on-year increase of 41.0% [1][7] - The growth of the wind power sector is expected to drive further investments in offshore wind power, leading to increased demand for wind energy cables [1][7] Wind Energy Cable Industry Overview - Wind energy cables are designed for the unique environments of wind power generation systems, featuring high-pressure current capacity, high-temperature resistance, and durability against environmental factors [3][6] - The cables are categorized into onshore and offshore types, with specific requirements for each based on their application [3][6] Industry Development Background - The Chinese government has prioritized the development of renewable energy, particularly in wind energy, as outlined in various policy documents [4][5] - The increasing demand for wind energy cables is driven by the growth of wind power projects and advancements in technology [4][5] Industry Chain - The wind energy cable industry consists of upstream raw materials (copper, aluminum, polyethylene, PVC), midstream manufacturing, and downstream wind power applications [5][6] Current Industry Status - The cumulative installed capacity of wind power in China reached 580 million kilowatts by September 2025, with a year-on-year growth of 21.3% [6] - Wind energy cables play a crucial role in connecting various components of wind power systems and transmitting generated electricity to the grid [6][7] Competitive Landscape - The wind energy cable market has traditionally been dominated by established companies from Europe, the US, Japan, and South Korea, but Chinese companies are rapidly gaining market share [7][8] - Key domestic players include Zhongtian Technology, Hengtong Optic-Electric, and Oriental Cable, with notable advancements in technology and market presence [7][8] Industry Development Trends - The wind energy cable industry is expected to evolve towards higher performance, efficiency, and smart technology applications [11][12] - The market size is anticipated to continue growing rapidly due to increasing global emphasis on renewable energy and offshore wind power development [11][12] - Companies are likely to expand into overseas markets, leveraging technological advancements and addressing global demand gaps [12]

证券日报网讯尚纬股份（603333）11月25日在互动平台回答投资者提问时表示，截至2025年9月30日， 公司股东户数为30，042户。 ...

格隆汇11月25日丨尚纬股份(603333.SH)在投资者互动平台表示，公司目前未直接开展出口业务，主要 通过与大型央企、国企合作参与国际市场竞争。 （原标题：尚纬股份(603333.SH)：公司目前未直接开展出口业务） ...

分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]

Core Viewpoint - The company plans to increase its stake in Sichuan Zhongfu Taihua New Material Technology Co., Ltd. to 51% through a capital increase, which is expected to significantly enhance its profitability and operational stability through a dual-driven strategy of "cables + chemicals" [2][7]. Group 1: Investment and Growth Potential - The capital increase will raise Sichuan Zhongfu Taihua's registered capital from 500 million to 1.02 billion yuan, with the company holding 51% of the shares [3]. - Sichuan Zhongfu Taihua is set to enter a capacity release phase in 2026, with new production capacities including 200,000 tons/year of hydrogen peroxide, 60,000 tons of electronic-grade anhydrous hydrogen fluoride, and 70,000 tons of electronic-grade hydrofluoric acid [2][4]. - The company has committed to achieving a net profit of no less than 180 million yuan from 2026 to 2028, which is expected to significantly improve the profitability of the parent company [4][6]. Group 2: Risk Mitigation Measures - The investment includes performance compensation and loss buyback clauses, ensuring that if profit targets are not met, the controlling shareholder will compensate the difference in cash [5][6]. - If Sichuan Zhongfu Taihua incurs losses from 2026 to 2028, the controlling shareholder will buy back the shares at the investment price plus interest, providing a safeguard for the company's investment [6]. Group 3: Business Strategy and Financial Health - The company aims to expand into electronic chemicals and related basic chemicals, while maintaining its core business in special cables, thus establishing a dual-driven growth model [7]. - As of October 31, 2025, the company has a debt-to-asset ratio of 29.02% and sufficient liquidity with cash reserves of 490 million yuan and a bank credit line of 310 million yuan [7][8]. - The capital increase will not dilute earnings per share as it does not involve issuing new shares, and the existing cable business will continue to operate normally [8]. Group 4: Market Expansion and Structural Optimization - Following the change in controlling shareholder, the company has initiated internal management upgrades and external channel expansions, including establishing marketing offices in key domestic and international locations [9]. - The strategy to grow both the cable and chemical businesses will optimize the company's business structure and reduce reliance on a single business, enhancing its resilience and sustainable development [9].

本资产评估报告依据中国资产评估准则编制 尚纬股份有限公司拟增资涉及的 四川中氟泰华新材料科技有限公司 股东全部权益价值 资产评估报告 嘉学评估评报字〔2025〕8310099号 第一册（共一册） 二零二五年十一月十八日 | 报告编码: | 3239020006321801202500096 | | --- | --- | | 合同编号: | 嘉学评合字 2025 831090A号 | | 报告类型: | 法定评估业务资产评估报告 | | 报告文号: | 嘉学评估评报字(2025) 8310099号 | | 报告名称: | 尚纬股份有限公司拟增资涉及的四川中氟泰华新材料科技有限公 司股东全部权益价值资产评估报告 | | 评估结论: | 495.761.500.00元 | | 评估报告日 : | 2025年11月18日 | | 评估机构名称: | 厦门嘉学资产评估房地产估价有限公司 | | 签名人员: | (资产评估师) 刘磊 正式会员 编号:32200056 | | | 刘国帅 (资产评估师) 正式会员 编号:39200040 | | | 刘磊、刘国帅已实名认可 | | 声明 1 | | --- | | 摘要 ...

审计报告 四川中氟泰华新材料科技有限公司 容诚审字[2025]200F2421 号 容诚会计师事务所(特殊普通合伙)上海分所 中国·上海 目 录 | 序号 | 内 容 | 页码 | | --- | --- | --- | | 1 | 审计报告 | 1 - 4 | | 2 | 模拟合并资产负债表 | 1 | | 3 | 模拟合并利润表 | 2 | | 4 | 模拟合并现金流量表 | 3 | | 5 | 模拟合并所有者权益变动表 | 4-5 | | 6 | 模拟财务报表附注 | 6-62 | 审 计 报 告 容诚会计师事务所(特殊普通合伙)上海分所 中国（上海）自由贸易试验区南泉北路 429 号 2201-2202 室（200120） TEL: 021-6840 6125 FAX: 021-6840 6125 容诚审字[2025]200F2421 号 尚纬股份有限公司董事会： 一、审计意见 我们审计了四川中氟泰华新材料科技有限公司（以下简称"中氟泰华"）的模拟 财务报表，包括 2024 年 12 月 31 日及 2025 年 9 月 30 日的模拟合并资产负债表， 2024 年度及 2025 年 1 至 9 月的 ...